Loading clinical trials...
Loading clinical trials...
Study of whether the investigational drug CE-326,597 improves glucose control and results in body weight loss in patients with type 2 diabetes
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT07049861 · Weight Management, Obesity Prevention, and more
NCT07426952 · Breast Cancer Survivorship, Weight Management, and more
NCT07243171 · Overweight and/or Obesity, Weight Management
NCT07089823 · Weight Management
NCT06691100 · Weight Management, Obesity, and more
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Fresno, California
Pfizer Investigational Site
National City, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions